• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Neurophysiol . Electrophysiological assessment in patients with COVID-19 related peripheral neuropathies: A systematic review

tetano

Editor, Senior Moderator
J Neurophysiol


. 2022 Dec 7.
doi: 10.1152/jn.00386.2022. Online ahead of print.
Electrophysiological assessment in patients with COVID-19 related peripheral neuropathies: A systematic review


Sarah Al-Mazidi[SUP] 1 [/SUP], Lina Al-Dakhil[SUP] 2 [/SUP]



Affiliations

Abstract

Background: Neurological manifestations associated with Coronavirus Disease-2019 (COVID-19) are commonly reported, but patients were not referred to perform the electrophysiological assessment.
Aim: we aimed to review the existing literature on clinical studies on COVID-19 peripheral neuropathy to correlate patients' symptoms and characteristics with nerve conduction studies/electromyography (NCS/EMG) outcomes.
Methods: This protocol is registered in the Open Science Framework (OSF) (DOI: 10.17605/OSF.IO/ZF4PK.). The systematic search included PubMed, ScienceDirect, and Google Scholar, for articles published from December 2019 to March 2022. A total of 727 articles were collected, and according to our inclusion and exclusion criteria, only six articles were included.
Results: Of 195 participants, only 175 underwent NCS/EMG assessment. Of these: 44 participants (25.1%) had abnormal EMG, 54 participants (30.8%) had abnormal motor NCS, and only 7 participants (4%) had abnormal sensory NCS. All cases presented with myopathy, while a limited number of cases presented with polyneuropathy. According to motor NCS and EMG, the most affected nerves were the tibial and peroneal in the lower extremities and the ulnar nerve in the upper extremities. Interestingly, the median nerve was reported to be associated with the severity and the rate of motor recovery of COVID-19 patients.
Conclusion: COVID-19 generates a demyelinating motor neuropathy and myopathy. Clinicians are encouraged to refer COVID-19 patients presenting with neurological symptoms to be assessed by electrophysiological methods to objectively determine the nature of their symptoms, follow their prognosis, and plan their rehabilitation.

Keywords: COVID-19; Electromyography; Nerve Conduction Studies; Periphral neuropathy.
 
Back
Top Bottom